- Home
- CALM vs LEGN Comparison
CALM vs LEGN Comparison
Compare CALM & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALM
- LEGN
- Stock Information
- Founded
- CALM 1957
- LEGN 2014
- Country
- CALM United States
- LEGN United States
- Employees
- CALM N/A
- LEGN N/A
- Industry
- CALM Farming/Seeds/Milling
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- CALM Consumer Staples
- LEGN Health Care
- Exchange
- CALM Nasdaq
- LEGN Nasdaq
- Market Cap
- CALM 4.5B
- LEGN 5.4B
- IPO Year
- CALM 1996
- LEGN 2020
- Fundamental
- Price
- CALM $96.38
- LEGN $36.83
- Analyst Decision
- CALM Sell
- LEGN Strong Buy
- Analyst Count
- CALM 3
- LEGN 12
- Target Price
- CALM $83.00
- LEGN $77.09
- AVG Volume (30 Days)
- CALM 655.9K
- LEGN 2.1M
- Earning Date
- CALM 07-22-2025
- LEGN 08-08-2025
- Dividend Yield
- CALM 6.99%
- LEGN N/A
- EPS Growth
- CALM 258.93
- LEGN N/A
- EPS
- CALM 20.24
- LEGN N/A
- Revenue
- CALM $3,799,016,000.00
- LEGN $728,303,000.00
- Revenue This Year
- CALM $76.88
- LEGN $65.17
- Revenue Next Year
- CALM N/A
- LEGN $53.86
- P/E Ratio
- CALM $4.76
- LEGN N/A
- Revenue Growth
- CALM 60.00
- LEGN 112.46
- 52 Week Low
- CALM $57.56
- LEGN $27.34
- 52 Week High
- CALM $116.41
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- CALM 52.54
- LEGN 64.82
- Support Level
- CALM $91.70
- LEGN $28.16
- Resistance Level
- CALM $98.73
- LEGN $39.36
- Average True Range (ATR)
- CALM 2.43
- LEGN 1.84
- MACD
- CALM -0.17
- LEGN 1.04
- Stochastic Oscillator
- CALM 66.57
- LEGN 77.77
About CALM Cal-Maine Foods Inc.
Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.